Inside the Term-Sheet Mindset of a Life Sciences VC
This article was originally published in Start Up
Executive Summary
When deal discussions get tough and there seems to be no way to cross the chasm between the entrepreneur's valuation expectations and the VC's choking point, the savvy professional investor will likely find a way to slant the secondary terms in order to achieve a deal that works.